[HTML][HTML] The evidence base for rotavirus vaccination in India: Current status, future needs

N Bhat, E Vodicka, A Clifford, KB Ananth, A Bavdekar… - Vaccine, 2025 - Elsevier
Rotavirus is a leading cause of severe diarrheal disease in infants and young children
worldwide. Vaccination offers the best protection against this disease, and two rotavirus …

Combatting infectious diarrhea: innovations in treatment and vaccination strategies

VP Chavda, S Vuppu, T Mishra, S Kamaraj… - Expert Review of …, 2024 - Taylor & Francis
Introduction The escalating prevalence of infectious diseases is an important cause of
concern in society. Particularly in several developing countries, infectious diarrhea poses a …

Clinical profile of children under 5 years of age with rotavirus diarrhoea in a hospital setting in Kisangani, DRC, after the introduction of the rotavirus vaccine, a cross …

D Gbebangi-Manzemu, VM Kampunzu, HM Vanzwa… - BMC pediatrics, 2023 - Springer
Abstract Background The Democratic Republic of the Congo (DRC) is one of the countries
with the highest rotavirus mortality rate in the world. The aim of this study was to describe the …

Immunogenicity of RV1 and RV5 vaccines administered in standard and interchangeable mixed schedules: a randomized, double-blind, non-inferiority clinical trial in …

M Macías-Parra, P Vidal-Vázquez… - Frontiers in Public …, 2024 - frontiersin.org
Introduction Rotavirus-associated diarrheal diseases significantly burden healthcare
systems, particularly affecting infants under five years. Both Rotarix™(RV1) and …

[HTML][HTML] Mannose and Lactobionic Acid in Nasal Vaccination: Enhancing Antigen Delivery via C-Type Lectin Receptors

M Colaço, MT Cruz, LP Almeida, O Borges - Pharmaceutics, 2024 - mdpi.com
Background/Objectives: Nasal vaccines are a promising strategy for enhancing mucosal
immune responses and preventing diseases at mucosal sites by stimulating the secretion of …

The considerable complexities of rotavirus vaccination

KH Keddy - The Lancet Infectious Diseases, 2022 - thelancet.com
Americas, 67% in the eastern Mediterranean region, and 46% in southeast Asia, including
most countries on the Indian subcontinent (Bangladesh, Bhutan, and Sri Lanka are planning …

Learning from the bone allograft tuberculosis outbreak in the USA

C Hill, D Purtill - The Lancet Infectious Diseases, 2022 - thelancet.com
Among the diverse fields of organ, cell, and tissue transplantation, the risk of infectious
disease transmission from donor to recipient is common. Mitigating this threat requires …

Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trial

ZW Wu, F Jin, QL Li, JM Gao, HS Zhou… - Human Vaccines & …, 2023 - Taylor & Francis
Rotavirus remains a major cause of diarrhea among 5-y-old children, and vaccination is
currently the most effective and economical measure. We conducted a randomized, double …

Vaccine pragmatism in the 21st century

KH Keddy - The Lancet Infectious Diseases, 2022 - thelancet.com
One of the many lessons of the past 2 years has been the additional challenges faced by
low-income and middle-income countries in accessing and distributing vaccines. Although …

Eru tengsl milli rótaveirusýkinga hjá ungbörnum og astma, ofnæmis eða sýkinga síðar í barnæsku?

A Indriðadóttir - skemman.is
Inngangur: Algengasta orsök bráðra iðrasýkingar hjá ungum börnum er rótaveirusýking.
Rótaveirusýkingar geta haft margvísleg áhrif á börn á meðan veikindum stendur og …